Coloplast A/S:企業の戦略・SWOT・財務情報

◆英語タイトル:Coloplast A/S - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C13455
◆発行会社(調査会社):MarketLine
◆発行日:2019年2月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Coloplast A/S – Strategy, SWOT and Corporate Finance Report
Summary

Coloplast A/S – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Coloplast A/S (Coloplast or ‘the company’) is a healthcare company involved in developing and marketing products and services for the treatment of people with very private and personal medical conditions. It offers a range of products including ostomy care products, continence care products, wound care products, skin care products, and surgical urology related products. Coloplast markets its products under brands such as Assura, Alterna, Biatain Biatain Silicone, Brava, Comfeel, Peristeen, Porges, Restorelle, SenSura, SenSura Mio Convex, SpeediCath, SpeediCath Flex and Titan. The company distributes its products to hospitals, institutions as well as wholesalers and pharmacies. It operates in Europe and other regions of the world. Coloplast is headquartered in Humlebaek, Denmark.

Scope

- Detailed information on Coloplast A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Coloplast A/S in the form of a SWOT analysis
- An in-depth view of the business model of Coloplast A/S including a breakdown and examination of key business segments
- Intelligence on Coloplast A/S’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Coloplast A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Coloplast A/S and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Coloplast A/S as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Coloplast A/S’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Coloplast A/S: Company Overview
Coloplast A/S: Overview and Key Facts
Coloplast A/S: Overview
Coloplast A/S: Key Facts
Coloplast A/S: Key Employees
Coloplast A/S: Key Employee Biographies
Coloplast A/S: Major Products and Services
Coloplast A/S: Company History
Coloplast A/S: Management Statement
Coloplast A/S: Locations and Subsidiaries
Coloplast A/S: Key Competitors
Coloplast A/S: Company Analysis
Coloplast A/S: Business Description
Coloplast A/S: SWOT Analysis
Coloplast A/S: SWOT Overview
Coloplast A/S: Strengths
Coloplast A/S: Weaknesses
Coloplast A/S: Opportunities
Coloplast A/S: Threats
Coloplast A/S: Corporate Financial Deals Activity
Coloplast A/S: Financial Deals Overview
Coloplast A/S: Targets and Partners
Coloplast A/S: Top Deals 2015 – 2019YTD*
Coloplast A/S: Mergers and Acquisitions
Coloplast A/S: Divestments
Coloplast A/S: Recent Developments
Coloplast A/S: News and Events Summary
Coloplast A/S: Contracts
Coloplast A/S: Corporate Governance
Coloplast A/S: Financial Performance
Coloplast A/S: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Coloplast A/S: Key Facts
Table 2: Coloplast A/S: Key Employees
Table 3: Coloplast A/S: Company History
Table 4: Coloplast A/S: Locations and Subsidiaries
Table 5: Coloplast A/S: Key Competitors
Table 6: Coloplast A/S: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Coloplast A/S: M&A Average Deal Size - Value (US$m)
Table 8: Coloplast A/S: Targets and Partners
Table 9: Coloplast A/S: Top Deals 2015 - 2019YTD*
Table 10: Coloplast A/S: M&A Volume and Value Trend (2015 - YTD*2019)
Table 11: Coloplast A/S: M&A Activity by Geography (2015 - YTD*2019)
Table 12: Coloplast A/S: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 13: Coloplast A/S: News and Events Summary
Table 14: Coloplast A/S: Contracts
Table 15: Coloplast A/S: Corporate Governance
Table 16: Coloplast A/S: Financial Performance
Table 17: Coloplast A/S: Strategy and Operations

List of Figures
Figure 1: Coloplast A/S: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 2: Coloplast A/S: M&A Average Deal Size - Value (US$m)
Figure 3: Coloplast A/S: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 4: Coloplast A/S: M&A Activity by Geography (2015 - YTD*2019)
Figure 5: Coloplast A/S: Divestments Volume and Value Trend (2015 - YTD*2019)

★海外企業調査レポート[Coloplast A/S:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Japan Tobacco Inc (2914):製薬・医療:M&Aディール及び事業提携情報
    Summary Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes. It also manufactures, markets and sells varied pharmaceutical and processed food products such as frozen cooked rice and noodles, instant noodles, bread and frozen bread, mineral water, and seasoning, p …
  • Regenera Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Regenera Pharma Ltd (Regenera Pharma) is a pharmaceutical company that develops a novel drug for neurological indications. The company provides product RPh201, which is a botanical drug developed to repair permanent damages caused by neurological diseases that afflict the central nervous sys …
  • Filtronic plc:企業の戦略・SWOT・財務分析
    Filtronic plc - Strategy, SWOT and Corporate Finance Report Summary Filtronic plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hellenic Petroleum SA (ELPE):企業の財務・戦略的SWOT分析
    Hellenic Petroleum SA (ELPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • DFDS AS (DFDS):企業の財務・戦略的SWOT分析
    DFDS AS (DFDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Black Hills Corporation (BKH):電力:M&Aディール及び事業提携情報
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …
  • Archroma Management GmbH:企業の戦略的SWOT分析
    Archroma Management GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • New China Life Insurance Company Ltd.:戦略・SWOT・企業財務分析
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • AGR Holdings AS:企業の戦略的SWOT分析
    AGR Holdings AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Sino Gas & Energy Holdings Ltd (SEH):企業の財務・戦略的SWOT分析
    Summary Sino Gas & Energy Holdings Ltd (Sino Gas), a subsidiary of MIE Holdings Corp, is an oil and gas company that explores and develops unconventional gas assets production sharing contracts. The company holds working interest in the Linxing PSC and the Sanjiaobei PSC projects. It has strategic A …
  • Nymox Pharmaceutical Corp (NYMX):医療機器:M&Aディール及び事業提携情報
    Summary Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the …
  • TearScience Inc:医療機器:M&Aディール及び事業提携情報
    Summary TearScience Inc (TearScience) is a medical device company that carries out identifying, diagnosing, and treating meibomian gland dysfunction (MGD). The company conducts early detection and treatment of prevalent, chronic, and progressive MGD. It offers LipiFlow thermal pulsation system, a si …
  • Church & Dwight Co Inc:企業の戦略・SWOT・財務情報
    Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report Summary Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Myovant Sciences Ltd (MYOV):製薬・医療:M&Aディール及び事業提携情報
    Summary Myovant Sciences Ltd (Myovant), a subsidiary of Roivant Sciences Ltd, is a biopharmaceutical company that develops and commercializes new treatments for women’s diseases and endocrine disorders. The company’s products include relugolix, an oral small molecule that functions as a gonadotropin …
  • Lloyds Banking Group Plc:戦略・SWOT・企業財務分析
    Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kokuyo Camlin Ltd (KOKUYOCMLN):企業の財務・戦略的SWOT分析
    Kokuyo Camlin Ltd (KOKUYOCMLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Orange Polska S.A.:戦略・SWOT・企業財務分析
    Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • TenCate Advanced Armour:企業の戦略・SWOT・財務情報
    TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report Summary TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Energy Fuels Inc (EFR):企業の財務・戦略的SWOT分析
    Energy Fuels Inc (EFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆